Company Filing History:
Years Active: 2020-2025
Title: Winfried Krueger - Innovator in Cancer Treatment
Introduction
Winfried Krueger is a distinguished inventor residing in Kensington, MD, known for his groundbreaking contributions to cancer treatment. With a total of two patents to his name, he focuses on innovative methodologies that leverage engineered T-cells for cancer therapies.
Latest Patents
His latest invention revolves around a method to treat cancer utilizing engineered T-cells. This patent details novel adoptive immunotherapy compositions that consist of co-cultured lentiviral vector-transduced autologous antigen presentation cells and T-cells. The methods outlined in his patent elaborate on patient-specific combination immunotherapy that holds promise for treating various cancers and other diseases.
Career Highlights
Winfried is affiliated with Lentigen Technology, Inc., a company that specializes in developing innovative cell and gene therapies. His work there significantly contributes to the evolving field of cancer treatment, utilizing advanced biotechnological approaches to enhance patient outcomes.
Collaborations
Throughout his career, Winfried has collaborated with notable colleagues, including Boro Dropulic and Rimas J Orentas. Their combined expertise in biomedical research and innovation fosters a collaborative environment that enhances the development of cutting-edge therapies.
Conclusion
Winfried Krueger's contributions to cancer treatment through his inventions exemplify the critical intersection of research and application in modern medicine. His focus on engineered T-cells reflects a promising future for immunotherapy, marking him as a key player in the field of cancer therapy innovation.